COMMUNIQUÉS West-GlobeNewswire

pSivida's Second Phase 3 Study for Durasert™ Three-year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months
07/02/2018
Highly Significant Difference Between Durasert and Sham in Prevention of Uveitis Recurrence at 12 Months Fiscal Q2 2018 Results Conference Call Scheduled for Today at 4:30 p.m.ET WATERTOWN, Mass., Feb. 07, 2018 (GLOBE [...]
Amicus Therapeutics Announces Additional Positive Data in Pompe Disease Phase 1/2 Study at 14th Annual WORLDSymposium™
07/02/2018
Consistent and Durable Responses Across Key Measures of Safety, Functional Outcomes and Biomarkers Out to Month 12 Very Low Rate (<1%) of Infusion Associated Reactions Maintained After 550+ Infusions CRANBURY, N.J. [...]
Adverum Biotechnologies Announces Proposed Public Offering of Common Stock
07/02/2018
MENLO PARK, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]
Cara Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference
07/02/2018
STAMFORD, Conn., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]
Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus
07/02/2018
SAN DIEGO and TORONTO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics that [...]
OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results
07/02/2018
BETHLEHEM, Pa., Feb. 07, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial [...]
The American College of Rheumatology Recommends Biosimilar Use in New White Paper
07/02/2018
Atlanta, Feb. 07, 2018 (GLOBE NEWSWIRE) -- The American College of Rheumatology (ACR) has published a new white paper , “The Science Behind Biosimilars – Entering a New Era of Biologic Therapy,” providing a [...]
Aviragen and Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen Stockholders
07/02/2018
ATLANTA and SOUTH SAN FRANCISCO, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ: AVIR ) and Vaxart, Inc. today announced that the companies have agreed to amend the terms of their [...]
Adamas to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
07/02/2018
EMERYVILLE, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that Gregory T. Went, Ph.D., Founder, Chairman and Chief Executive Officer of Adamas, is scheduled to [...]
Rutgers New Jersey Medical School Selects Alpha Clinical Systems ACS360 eSource Platform for Clinical Trial Data Capture
07/02/2018
PISCATAWAY, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Alpha Clinical Systems, the leading provider of affordable and comprehensive next-generation eSource solutions, today announced that Rutgers New Jersey Medical School [...]
Corizon Health Names New CFO
07/02/2018
BRENTWOOD, Tenn., Feb. 07, 2018 (GLOBE NEWSWIRE) -- To help meet Corizon Health’s goal of redefining the nation’s standard of excellence for correctional healthcare, CEO Steve Rector today announced Shalin Shah has [...]
News Release: Changes to Essilor International (Compagnie Générale d'Optique) Board of Directors
07/02/2018
Changes to Essilor International (Compagnie Générale d'Optique) Board of Directors PDF Version of the news release Charenton-le-Pont, France (February 7, 2018 - 6:00 p.m.) - The Board of Directors of Essilor [...]
Communiqué : Evolution de la composition du Conseil d'administration d'Essilor International (Compagnie Générale d'Optique)
07/02/2018
Evolution de la composition du Conseil d'administration d'Essilor International (Compagnie Générale d'Optique) Version PDF du communiqué Charenton-le-Pont, France (le 7 février 2018 - 18h00) - Le Conseil d' [...]
Voyager Therapeutics to Present at Leerink Partners Annual Global Healthcare Conference
07/02/2018
CAMBRIDGE, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced [...]
Innovate Biopharmaceuticals to Highlight Progress in Celiac Disease and NASH at BIO CEO & Investor Conference on Monday, February 12, 2018 at 3:30PM ET
07/02/2018
RALEIGH, N.C., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT ) a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced [...]
Orphan’s Court of City of Jurmala Has Appointed Older Daughter of Valerijs Maligins to be the Guardian of His Inheritance
07/02/2018
Olaine, 2018-02-07 16:18 CET (GLOBE NEWSWIRE) -- Orphan’s court of the City of Jurmala, after assessing the application of Irina Maligina has appointed her the guardian of inheritance of Valerijs Maligins, the verdict [...]
Amended News Release - Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc.
07/02/2018
CONCORD, Ontario, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Aspri Pharma Canada Inc. (“ Aspri ), a pharmaceutical products wholesale and manufacturer corporation, announces that on February 1, 2018, Devonian Health Group Inc [...]
Tyme Provides Clinical and Corporate Update for Fiscal Third Quarter 2017
07/02/2018
NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced a clinical and corporate update for the fiscal [...]
Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral Betahistine
07/02/2018
Single dose animal study demonstrates 5 to 35 times higher bioavailability of intranasal betahistine relative to oral betahistine Bioavailability of intranasal betahistine in humans estimated to be 20 to 40 times higher [...]

Pages